| A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer V Jain, H Kumar, HV Anod, P Chand, NV Gupta, S Dey, SS Kesharwani Journal of Controlled Release 326, 628-647, 2020 | 179 | 2020 |
| Enhanced transdermal delivery of an anti-HIV agent via ethanolic liposomes V Dubey, D Mishra, M Nahar, V Jain, NK Jain Nanomedicine: Nanotechnology, Biology and Medicine 6 (4), 590-596, 2010 | 137 | 2010 |
| Paclitaxel loaded PEGylated gleceryl monooleate based nanoparticulate carriers in chemotherapy V Jain, NK Swarnakar, PR Mishra, A Verma, A Kaul, AK Mishra, NK Jain Biomaterials 33 (29), 7206-7220, 2012 | 135 | 2012 |
| Enhanced oromucosal delivery of progesterone via hexosomes NK Swarnakar, V Jain, V Dubey, D Mishra, NK Jain Pharmaceutical research 24, 2223-2230, 2007 | 128 | 2007 |
| Gemcitabine-loaded smart carbon nanotubes for effective targeting to cancer cells R Singh, NK Mehra, V Jain, NK Jain Journal of drug targeting 21 (6), 581-592, 2013 | 68 | 2013 |
| Effect of different viscosity grade HPMC polymers on gastroretentive drug delivery of metformin HCl RV Kshirsagar, V Jain, S Wattamwar Int J Appl Pharm 1 (1), 44-50, 2009 | 38 | 2009 |
| Role of Nrf2 signaling cascade in breast cancer: strategies and treatment H Kumar, RM Kumar, D Bhattacharjee, P Somanna, V Jain Frontiers in Pharmacology 13, 720076, 2022 | 37 | 2022 |
| Design and evaluation of cabazitaxel loaded NLCs against breast cancer cell lines P Chand, H Kumar, N Badduri, NV Gupta, VG Bettada, ... Colloids and Surfaces B: Biointerfaces 199, 111535, 2021 | 32 | 2021 |
| An overview of advanced formulation and nanotechnology-based approaches for solubility and bioavailability enhancement of silymarin SS Kesharwani, V Jain, S Dey, S Sharma, P Mallya, VA Kumar Journal of Drug Delivery Science and Technology 60, 102021, 2020 | 27 | 2020 |
| A comparison of Natural and Synthetic Sunscreen Agents: A Review. D BHATTACHARJEE, AB PATIL, V JAIN International Journal of Pharmaceutical Research (09752366) 13 (1), 2021 | 25 | 2021 |
| Nobiletin as a molecule for formulation development: an overview of advanced formulation and nanotechnology-based strategies of nobiletin SS Kesharwani, P Mallya, VA Kumar, V Jain, S Sharma, S Dey Aaps Pharmscitech 21, 1-13, 2020 | 23 | 2020 |
| Fisetin in cancer: attributes, developmental aspects, and nanotherapeutics RM Kumar, H Kumar, T Bhatt, R Jain, K Panchal, A Chaurasiya, V Jain Pharmaceuticals 16 (2), 196, 2023 | 22 | 2023 |
| Role of STAT3 in the initiation, progression, proliferation and metastasis of breast cancer and strategies to deliver JAK and STAT3 inhibitors YH Dinakar, H Kumar, SL Mudavath, R Jain, R Ajmeer, V Jain Life Sciences 309, 120996, 2022 | 22 | 2022 |
| A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer H Kumar, NV Gupta, R Jain, SRV Madhunapantula, CS Babu, ... Journal of Advanced Research 54, 271-292, 2023 | 20 | 2023 |
| Review on NAD (P) H dehydrogenase quinone 1 (NQO1) pathway S Preethi, K Arthiga, AB Patil, A Spandana, V Jain Molecular Biology Reports 49 (9), 8907-8924, 2022 | 20 | 2022 |
| Novel gels: an emerging approach for delivering of therapeutic molecules and recent trends TK Sastri, VN Gupta, S Chakraborty, S Madhusudhan, H Kumar, P Chand, ... Gels 8 (5), 316, 2022 | 16 | 2022 |
| Challenges in formulating herbal cosmetics SS DK, V Jain Int J App Pharm 10 (6), 47-53, 2018 | 15 | 2018 |
| Organ-restricted delivery through stimuli-responsive nanocarriers for lung cancer therapy YH Dinakar, A Karole, S Parvez, V Jain, SL Mudavath Life Sciences 310, 121133, 2022 | 14 | 2022 |
| An overview on medicinal plants for the treatment of acne DM Reddy, V Jain J. Crit. Rev 6 (6), 7-14, 2019 | 14 | 2019 |
| Multi drug resistance in cancer therapy-an overview H Kadkol, V Jain, AB Patil J. Crit. Rev 6 (6), 1-6, 2019 | 14 | 2019 |
AMIT B PATILAssistant Professor of Pharmaceutics, JSS College of Pharmacy, MysuruDirección de correo verificada de jssuni.edu.in
